{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:38:28Z","timestamp":1775871508828,"version":"3.50.1"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Tuberculosis (TB) continues to be a major global health burden, with high incidence and mortality rates, compounded by the emergence and spread of drug-resistant strains. The limitations of current TB medications and the urgent need for new drugs targeting drug-resistant strains, particularly multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, underscore the pressing demand for innovative anti-TB drugs that can shorten treatment duration. This has led to a focus on targeting energy metabolism of <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (Mtb) as a promising approach for drug discovery. This study focused on repurposing drugs against the crucial mycobacterial protein, electron transfer flavoprotein oxidoreductase (EtfD), integral to utilizing fatty acids and cholesterol as a carbon source during infection. The research adopted an integrative approach, starting with virtual screening of approved drugs from the ZINC20 database against EtfD, followed by molecular docking, and concluding with molecular dynamics (MD) simulations. Diacerein, levonadifloxacin, and gatifloxacin were identified as promising candidates for repurposing against TB based on their strong binding affinity, stability, and interactions with EtfD. ADMET analysis and anti-TB sensitivity predictions assessed their pharmacokinetic and therapeutic potential. Diacerein and levonadifloxacin, previously unexplored in anti-tuberculous therapy, along with gatifloxacin, known for its efficacy in drug-resistant TB, have broad-spectrum antimicrobial properties and favorable pharmacokinetic profiles, suggesting potential as alternatives to current TB treatments, especially against resistant strains. This study underscores the efficacy of computational drug repurposing, highlighting bacterial energy metabolism and lipid catabolism as fruitful targets. Further research is necessary to validate the clinical suitability and efficacy of diacerein, levonadifloxacin, and gatifloxacin, potentially enhancing the arsenal against global TB.<\/jats:p>","DOI":"10.1371\/journal.pone.0312860","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T18:26:29Z","timestamp":1731695189000},"page":"e0312860","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrated virtual screening and MD simulation study to discover potential inhibitors of mycobacterial electron transfer flavoprotein oxidoreductase"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4097-8126","authenticated-orcid":true,"given":"Kaleem","family":"Arshad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahanzab","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ali","family":"Talat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asifa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"pone.0312860.ref001","unstructured":"World Health Organization. Global tuberculosis report 2023 [Internet]. Geneva: World Health Organization; 2023. https:\/\/iris.who.int\/handle\/10665\/373828"},{"key":"pone.0312860.ref002","doi-asserted-by":"crossref","first-page":"101574","DOI":"10.1016\/j.cimid.2020.101574","article-title":"Drug resistant Tuberculosis: A review","volume":"74","author":"JL Khawbung","year":"2021","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"6","key":"pone.0312860.ref003","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nchembio884","article-title":"Diarylquinolines target subunit c of mycobacterial ATP synthase","volume":"3","author":"A Koul","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"1","key":"pone.0312860.ref004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-015-0905-0","article-title":"Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates","volume":"15","author":"Z Zhang","year":"2015","journal-title":"BMC Infect Dis"},{"key":"pone.0312860.ref005","doi-asserted-by":"crossref","first-page":"113139","DOI":"10.1016\/j.ejmech.2020.113139","article-title":"Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis","volume":"212","author":"M Urban","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"2","key":"pone.0312860.ref006","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00272-17","article-title":"Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery","volume":"8","author":"D Bald","year":"2017","journal-title":"MBio"},{"issue":"8","key":"pone.0312860.ref007","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1021\/bi9016186","article-title":"Triazaspirodimethoxybenzoyls as selective inhibitors of mycobacterial lipoamide dehydrogenase","volume":"49","author":"R Bryk","year":"2010","journal-title":"Biochemistry"},{"issue":"6","key":"pone.0312860.ref008","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1074\/jbc.RA118.005732","article-title":"Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria","volume":"294","author":"BS Lee","year":"2019","journal-title":"J Biol Chem"},{"issue":"8","key":"pone.0312860.ref009","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41579-018-0013-4","article-title":"Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis","volume":"16","author":"S Ehrt","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"pone.0312860.ref010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.micinf.2007.05.020","article-title":"Enhanced mortality despite control of lung infection in mice aerogenically infected with a Mycobacterium tuberculosis mce1 operon mutant","volume":"9","author":"P Lima","year":"2007","journal-title":"Microbes Infect"},{"issue":"1","key":"pone.0312860.ref011","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1038\/s41467-021-26941-1","article-title":"Multiple acyl-CoA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection","volume":"12","author":"T Beites","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0312860.ref012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/imr.12952","article-title":"Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis","volume":"301","author":"T Laval","year":"2021","journal-title":"Immunol Rev"},{"issue":"2","key":"pone.0312860.ref013","doi-asserted-by":"crossref","first-page":"fty021","DOI":"10.1093\/femspd\/fty021","article-title":"Cholesterol and fatty acids grease the wheels of Mycobacterium tuberculosis pathogenesis","volume":"76","author":"KM Wilburn","year":"2018","journal-title":"Pathog Dis"},{"key":"pone.0312860.ref014","doi-asserted-by":"crossref","first-page":"145407","DOI":"10.1016\/j.gene.2021.145407","article-title":"Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease","volume":"776","author":"BJ Henriques","year":"2021","journal-title":"Gene"},{"key":"pone.0312860.ref015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/9781555819569.ch14","article-title":"Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions","author":"GM Cook","year":"2017","journal-title":"Tuberc Tuber Bacillus"},{"issue":"23","key":"pone.0312860.ref016","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1016\/j.febslet.2005.08.028","article-title":"Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids","volume":"579","author":"CJ Zheng","year":"2005","journal-title":"FEBS Lett"},{"issue":"18","key":"pone.0312860.ref017","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1089\/ars.2019.7867","article-title":"Reductive stress: new insights in physiology and drug tolerance of Mycobacterium","volume":"32","author":"PS Mavi","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"pone.0312860.ref018","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01139-20","article-title":"Inhibition of fatty acid oxidation promotes macrophage control of mycobacterium tuberculosis","volume":"11","author":"P Chandra","year":"2020","journal-title":"MBio"},{"issue":"11","key":"pone.0312860.ref019","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/acsinfecdis.0c00531","article-title":"6, 11-Dioxobenzo [f] pyrido [1, 2-a] indoles Kill Mycobacterium tuberculosis by Targeting Iron\u2014Sulfur Protein Rv0338c (IspQ), A Putative Redox Sensor","volume":"6","author":"R Sz\u00e9kely","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"9","key":"pone.0312860.ref020","doi-asserted-by":"crossref","first-page":"e1002251","DOI":"10.1371\/journal.ppat.1002251","article-title":"High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism","volume":"7","author":"JE Griffin","year":"2011","journal-title":"PLoS Pathog"},{"key":"pone.0312860.ref021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mib.2018.02.006","article-title":"Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents","volume":"45","author":"JC Evans","year":"2018","journal-title":"Curr Opin Microbiol"},{"key":"pone.0312860.ref022","unstructured":"World Health Organization. Global tuberculosis report 2022 [Internet]. Geneva: World Health Organization; 2022. https:\/\/iris.who.int\/handle\/10665\/363752"},{"issue":"12","key":"pone.0312860.ref023","doi-asserted-by":"crossref","first-page":"e1000585","DOI":"10.1371\/journal.pcbi.1000585","article-title":"Predicting protein ligand binding sites by combining evolutionary sequence conservation and 3D structure","volume":"5","author":"JA Capra","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"pone.0312860.ref024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","author":"S Dallakyan","year":"2015","journal-title":"Chem Biol Methods Protoc"},{"issue":"16","key":"pone.0312860.ref025","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"GM Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"1","key":"pone.0312860.ref026","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0312860.ref027","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"DE Pires","year":"2015","journal-title":"J Med Chem"},{"issue":"7","key":"pone.0312860.ref028","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1021\/acs.jcim.0c00362","article-title":"mycoCSM: using graph-based signatures to identify safe potent hits against mycobacteria","volume":"60","author":"DE Pires","year":"2020","journal-title":"J Chem Inf Model"},{"key":"pone.0312860.ref029","unstructured":"Schr\u00f6dinger, LLC. The PyMOL Molecular Graphics System, Version 3.0. 2015."},{"issue":"7873","key":"pone.0312860.ref030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"J Jumper","year":"2021","journal-title":"Nature"},{"issue":"21","key":"pone.0312860.ref031","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/bioinformatics\/btt473","article-title":"lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests","volume":"29","author":"V Mariani","year":"2013","journal-title":"Bioinformatics"},{"key":"pone.0312860.ref032","article-title":"AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences","author":"M Varadi","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0312860.ref033","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all\u2010atom structure validation","volume":"27","author":"CJ Williams","year":"2018","journal-title":"Protein Sci"},{"issue":"1","key":"pone.0312860.ref034","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1038\/s41467-021-24773-7","article-title":"flDPnn: Accurate intrinsic disorder prediction with putative propensities of disorder functions","volume":"12","author":"G Hu","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"pone.0312860.ref035","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1110\/ps.0236803","article-title":"Can correct protein models be identified?","volume":"12","author":"B Wallner","year":"2003","journal-title":"Protein Sci"},{"issue":"suppl_2","key":"pone.0312860.ref036","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"M Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pone.0312860.ref037","doi-asserted-by":"crossref","first-page":"D418","DOI":"10.1093\/nar\/gkac993","article-title":"InterPro in 2022","volume":"51","author":"T Paysan-Lafosse","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"pone.0312860.ref038","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"JJ Irwin","year":"2020","journal-title":"J Chem Inf Model"},{"issue":"5","key":"pone.0312860.ref039","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein\u2014ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"S Forli","year":"2016","journal-title":"Nat Protoc"},{"issue":"1","key":"pone.0312860.ref040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"C Tian","year":"2019","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"pone.0312860.ref041","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"J Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"pone.0312860.ref042","article-title":"AmberTools","author":"DA Case","year":"2023","journal-title":"J Chem Inf Model"},{"issue":"21","key":"pone.0312860.ref043","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/jz501780a","article-title":"Building water models: a different approach","volume":"5","author":"S Izadi","year":"2014","journal-title":"J Phys Chem Lett"},{"issue":"W1","key":"pone.0312860.ref044","doi-asserted-by":"crossref","first-page":"W537","DOI":"10.1093\/nar\/gks375","article-title":"H++ 3.0: automating p K prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations","volume":"40","author":"R Anandakrishnan","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"pone.0312860.ref045","doi-asserted-by":"crossref","first-page":"e0119264","DOI":"10.1371\/journal.pone.0119264","article-title":"Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis","volume":"10","author":"L. Mart\u00ednez","year":"2015","journal-title":"PloS One"},{"key":"pone.0312860.ref046","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration as an indicator of protein structure compactness","volume":"42","author":"MY Lobanov","year":"2008","journal-title":"Mol Biol"},{"key":"pone.0312860.ref047","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/bs.apcsb.2015.09.004","article-title":"Molecular dynamics: new frontier in personalized medicine","volume":"102","author":"P Sneha","year":"2016","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"9","key":"pone.0312860.ref048","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA. py: an efficient program for end-state free energy calculations","volume":"8","author":"BR Miller","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"D1","key":"pone.0312860.ref049","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"M Varadi","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"7983","key":"pone.0312860.ref050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41586-023-06510-w","article-title":"Clustering predicted structures at the scale of the known protein universe","volume":"622","author":"I Barrio-Hernandez","year":"2023","journal-title":"Nature"},{"issue":"11","key":"pone.0312860.ref051","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nbt.3988","article-title":"MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets","volume":"35","author":"M Steinegger","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"3","key":"pone.0312860.ref052","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7","article-title":"Why are \u201cnatively unfolded\u201d proteins unstructured under physiologic conditions?","volume":"41","author":"VN Uversky","year":"2000","journal-title":"Proteins Struct Funct Bioinforma"},{"issue":"5","key":"pone.0312860.ref053","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1042\/BST20160172","article-title":"The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease","volume":"44","author":"MM Babu","year":"2016","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"pone.0312860.ref054","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/jmbi.1999.3110","article-title":"Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm","volume":"293","author":"PE Wright","year":"1999","journal-title":"J Mol Biol"},{"key":"pone.0312860.ref055","doi-asserted-by":"crossref","unstructured":"Hubbard RE. Structure-based drug discovery: an overview. 2006;","DOI":"10.1039\/9781847552549"},{"key":"pone.0312860.ref056","doi-asserted-by":"crossref","first-page":"393738","DOI":"10.3389\/fphar.2018.00923","article-title":"Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview","volume":"9","author":"V Salmaso","year":"2018","journal-title":"Front Pharmacol"},{"issue":"6","key":"pone.0312860.ref057","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.drudis.2021.02.003","article-title":"Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts","volume":"26","author":"ZY Yang","year":"2021","journal-title":"Drug Discov Today"},{"issue":"2","key":"pone.0312860.ref058","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cmdc.201200428","article-title":"Fueling open\u2010source drug discovery: 177 small\u2010molecule leads against tuberculosis","volume":"8","author":"L Ballell","year":"2013","journal-title":"ChemMedChem"},{"issue":"14","key":"pone.0312860.ref059","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis","volume":"112","author":"MB Harbut","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"pone.0312860.ref060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijid.2014.12.031","article-title":"Repurposing\u2014a ray of hope in tackling extensively drug resistance in tuberculosis","volume":"32","author":"A Maitra","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"3","key":"pone.0312860.ref061","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00253-15","article-title":"Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria","volume":"6","author":"W Moreira","year":"2015","journal-title":"MBio"},{"issue":"30","key":"pone.0312860.ref062","doi-asserted-by":"crossref","first-page":"21142","DOI":"10.1074\/jbc.M114.572636","article-title":"Modification of rifamycin polyketide backbone leads to improved drug activity against rifampicin-resistant Mycobacterium tuberculosis","volume":"289","author":"A Nigam","year":"2014","journal-title":"J Biol Chem"},{"key":"pone.0312860.ref063","doi-asserted-by":"crossref","first-page":"173908","DOI":"10.1016\/j.ejphar.2021.173908","article-title":"A research update on the therapeutic potential of rhein and its derivatives","volume":"899","author":"L Cheng","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"pone.0312860.ref064","doi-asserted-by":"crossref","first-page":"110594","DOI":"10.1016\/j.biopha.2020.110594","article-title":"Diacerein: Recent insight into pharmacological activities and molecular pathways","volume":"131","author":"M Almezgagi","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"pone.0312860.ref065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13568-023-01594-z","article-title":"In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis","volume":"13","author":"C Fu","year":"2023","journal-title":"AMB Express"},{"key":"pone.0312860.ref066","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2014.04.001","article-title":"Rhein exerts pro-and anti-inflammatory actions by targeting IKK\u03b2 inhibition in LPS-activated macrophages","volume":"72","author":"Y Gao","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"pone.0312860.ref067","doi-asserted-by":"crossref","first-page":"100040","DOI":"10.1016\/j.tcsw.2020.100040","article-title":"Anti-tubercular derivatives of rhein require activation by the monoglyceride lipase Rv0183","volume":"6","author":"KA Abrahams","year":"2020","journal-title":"Cell Surf"},{"key":"pone.0312860.ref068","article-title":"Meeting the unmet need in the management of MDR gram-positive infections with oral bactericidal agent levonadifloxacin","volume":"2022","author":"Y Mehta","year":"2022","journal-title":"Crit Care Res Pract"},{"issue":"12","key":"pone.0312860.ref069","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1099\/jmm.0.001102","article-title":"Levonadifloxacin (WCK 771) exerts potent intracellular activity against Staphylococcus aureus in THP-1 monocytes at clinically relevant concentrations","volume":"68","author":"J Dubois","year":"2019","journal-title":"J Med Microbiol"},{"issue":"9","key":"pone.0312860.ref070","first-page":"583","article-title":"Levonadifloxacin arginine salt to treat acute bacterial skin and skin structure infection due to S. aureus including MRSA","volume":"56","author":"D Saxena","year":"2020","journal-title":"Drugs Today Barc Spain 1998"},{"key":"pone.0312860.ref071","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijid.2020.09.114","article-title":"Resistance pattern among contemporary Gram positive clinical isolates and in vitro activity of novel antibiotic, Levonadifloxacin (WCK 771)","volume":"101","author":"V Kongre","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"38","key":"pone.0312860.ref072","doi-asserted-by":"crossref","first-page":"e30412","DOI":"10.1097\/MD.0000000000030412","article-title":"The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis","volume":"101","author":"Y He","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"pone.0312860.ref073","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5588\/ijtld.14.0100","article-title":"Successful \u20189-month Bangladesh regimen\u2019for multidrug-resistant tuberculosis among over 500 consecutive patients","volume":"18","author":"KJM Aung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"pone.0312860.ref074","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1183\/09031936.00136312","article-title":"Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis","volume":"42","author":"GB Migliori","year":"2013","journal-title":"Eur Respir J"},{"issue":"9","key":"pone.0312860.ref075","doi-asserted-by":"crossref","first-page":"965","DOI":"10.5588\/ijtld.19.0053","article-title":"Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB","volume":"23","author":"A Van Deun","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0312860.ref076","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijid.2021.11.037","article-title":"High-dose gatifloxacin-based shorter treatment regimens for MDR\/RR-TB","volume":"115","author":"Q Nie","year":"2022","journal-title":"Int J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T18:26:50Z","timestamp":1731695210000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312860"}},"subtitle":[],"editor":[{"given":"Wagdy M.","family":"Eldehna","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0312860","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}